Evaluating Viedoc?
Here’s how OpenClinica compares for US trials.
If you’re a US-based clinical-stage biotech running under FDA oversight, here’s how OpenClinica and Viedoc compare on the things that matter most.
What “out of the box” actually means.
Not every EDC that claims Part 11 compliance means the same thing. Some require additional configuration or third-party CSV support. OpenClinica is built for the US regulatory environment as a baseline — not as an add-on.
OpenClinica vs. Viedoc
| OpenClinica | Viedoc | |
|---|---|---|
| EHR-to-EDC | Yes — direct pull, 450+ sites | No EHR-to-EDC module |
| Integrated patient recruitment | Yes — built into platform | No patient recruitment module |
| Dedicated CSM included | Yes — named, from day one | Support included; dedicated named CSM not confirmed at base tier |
| US-based operations & support | Yes — US-based team, 24/5 | Headquartered in Sweden; US office available |
If your study start date is real — your EDC timeline is the one variable you should control.
OpenClinica customers running Phase 1 and Phase 2 studies under FDA oversight go from contract to first patient in weeks. Pre-built study templates, a dedicated Customer Success Manager from day one, and a platform that doesn’t require a standing-up period before it can handle your protocol.
After 15 years as a customer, we can confidently say that OpenClinica continues to earn our trust. Their EDC has supported a range of projects for us — pediatric studies, early-phase safety work, later-phase evaluations. What keeps us coming back is their commitment to giving us everything we need and nothing we don’t.
— Andreas Habicht, CEO, Signifikans
Fast implementation. No enterprise overhead.
Ready for your next study.
Purpose-built for US clinical trials. Dedicated CSM from day one. EHR-to-EDC included.